The Impact of Vitamin D Supplementation in Hypertensive Vitamin D Deficient Patients.

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 16, 2024

Primary Completion Date

August 13, 2025

Study Completion Date

August 13, 2025

Conditions
HypertensionVitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

Vitamin D (Cholecalciferol )

The hypertensive patients with vitamin D deficiency will receive a Vitamin D capsule with a dose of 25,000 IU. They will be asked to receive a capsule per week for 8 subsequent weeks and re-visit the hospital two weeks from the final dose.

DIETARY_SUPPLEMENT

Placebo Capsule(s)

The hypertensive patients with vitamin D deficiency will receive a Placebo capsule. They will be asked to receive a capsule per week for 8 subsequent weeks and re-visit the hospital two weeks from the final dose.

Trial Locations (3)

46001

University of Sulaimani, College of Medicine (CoM-UoS), Sulaymaniyah

Ministry of Higher Education and Scientific research, University of Sulaimani, College of Medicine (CoM-UoS), Sulaymaniyah

Unknown

Anwar Sheikha Medical City/High quality hospitals, Sulaymaniyah

All Listed Sponsors
lead

University of Sulaimani

OTHER

NCT06645041 - The Impact of Vitamin D Supplementation in Hypertensive Vitamin D Deficient Patients. | Biotech Hunter | Biotech Hunter